Condition
Cannabis Use Disorder, Severe
Total Trials
6
Recruiting
3
Active
4
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (4)
P 2 (2)
Trial Status
Recruiting3
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06907979Not ApplicableRecruitingPrimary
Cannabis and Processing Emotions Study
NCT04567394Not ApplicableActive Not Recruiting
Cannabis Use Disorder Treatment Study
NCT04964739Not ApplicableCompleted
Gender/Sex & CUD Remission
NCT05064319Phase 2Recruiting
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
NCT06225232Phase 2Recruiting
Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
NCT04902092Not ApplicableCompleted
Brain Exercise and Addiction Trial
Showing all 6 trials